Characteristics of Andersen-Tawil Syndrome

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Andersen-Tawil SyndromeAndersen Syndrome
Trial Locations (7)

14642

University of Rochester School of Medicine and Dentistry, Rochester

66160

University of Kansas Medical Center, Kansas City

75390

University of Texas Southwestern Medical Center, Dallas

94143

University of California, San Francisco, San Francisco

N6A 5A5

London Health Sciences Centre, London

Unknown

University of Milan, Milan

Institute of Neurology and National Hospital for Neurology, London

All Listed Sponsors
collaborator

Office of Rare Diseases (ORD)

NIH

collaborator

Rare Diseases Clinical Research Network

NETWORK

collaborator

National Center for Research Resources (NCRR)

NIH

lead

University of Rochester

OTHER

NCT00521794 - Characteristics of Andersen-Tawil Syndrome | Biotech Hunter | Biotech Hunter